Economic Evaluation of Tofacitinib as Initial Medication in Adults With Rheumatoid Arthritis After Failure to Methotrexate in Chile

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.03.935
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Therapies for Active Rheumatoid Arthritis After Methotrexate Failure

Rheumatology: Current Research
2017English

Efficacy of Tofacitinib Monotherapy in Methotrexate-Naive Patients With Early or Established Rheumatoid Arthritis

RMD Open
RheumatologyAllergyImmunology
2016English

Limited Efficacy of Conventional DMARDs After Initial Methotrexate Failure in Patients With Recent Onset Rheumatoid Arthritis Treated According to the Disease Activity Score

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2007English

Pms41 - Cost-Effectiveness Analysis of Tofacitinib in Combination With Methotrexate in the Treatment of Moderate to Severe Rheumatoid Arthritis in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Patient-Reported Outcomes for Tofacitinib With and Without Methotrexate, or Adalimumab With Methotrexate, in Rheumatoid Arthritis: A Phase IIIB/IV Trial

RMD Open
RheumatologyAllergyImmunology
2019English

Experience With Tofacitinib in the Treatment of Resistant Rheumatoid Arthritis

Modern Rheumatology Journal
2015English

Cost-Effectiveness of Early Treatment With Originator Biologics or Their Biosimilars After Methotrexate Failure in Patients With Established Rheumatoid Arthritis

Advances in Therapy
MedicinePharmacology
2019English

Adalimumab With or Without Methotrexate in Juvenile Rheumatoid Arthritis

New England Journal of Medicine
Medicine
2008English

Effectiveness of Subcutaneously Administered Methotrexate in Patients With Rheumatoid Arthritis

Advances in Clinical and Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy